A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
Public ClinicalTrials.gov record NCT00440518. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see how safe and effective Lacosamide (LCM) is when taken by mouth, twice a day for up to 18 weeks to prevent migraines.
Study identification
- NCT ID
- NCT00440518
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 218 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2007 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- Jul 17, 2018
2007 – 2008
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Boulder | Colorado | 80304 | — |
| Not listed | Palm Beach Gardens | Florida | 33410 | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | Sunrise | Florida | 33351 | — |
| Not listed | Conyers | Georgia | 30094 | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Wellesley Hills | Massachusetts | 02481 | — |
| Not listed | Worcester | Massachusetts | 01605 | — |
| Not listed | Ann Arbor | Michigan | 48104 | — |
| Not listed | Springfield | Missouri | 65807 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Albany | New York | 12205 | — |
| Not listed | Greensboro | North Carolina | 27401 | — |
| Not listed | Matthews | North Carolina | 28105 | — |
| Not listed | Cleveland | Ohio | 44121 | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | San Antonio | Texas | 78258 | — |
| Not listed | Alexandria | Virginia | — | — |
| Not listed | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00440518, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00440518 live on ClinicalTrials.gov.